Intracellular metabolism and mechanism of action of antileukemic agents studied by means of automatic simulation system of drug concentration.
Intracellular metabolism and mechanism of action of antileukemic agents studied by means of automatic simulation system of drug concentration.
批准号:
06671083
负责人:
UEDA Takanori
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1996
中文摘要
在准确反映临床药代动力学的条件下研究抗白血病药物的代谢和作用具有重要意义。本年度,我们在去年建立的自动模拟系统调节药物浓度的条件下,采用台苯蓝染料排除试验(TB)和克隆实验(CA)的方法,研究了胞嘧啶arabinoside (ara-C)对白血病细胞系K562细胞生长的抑制作用。在临床常规剂量ara-C (100mg/ m2)与曲线下面积(AUC)相等的情况下,注射2、4、8、16 h后,TB组细胞生长分别为73%、53%、39%、45%,CA组细胞生长分别为76%、72%、34%、15%。ca法观察到ara-C具有明显的时间依赖性抑制作用,并通过模拟方法比较了柔红霉素(DNR)与常规培养系统的效果。在DNR 40mg/ m2 30min的模拟条件下,CA的细胞生长为对照组的82% (Cmax; 0.20 muM,t1/2beta; 4.35 hr)。另一方面,在常规培养体系条件下,需0.022 muM孵育24小时才能达到相同的生长抑制效果。与传统培养系统相比,自动模拟系统所需的浓度提高了约9倍。这一结果与去年ara-C的情况不同,相差约80倍,这可能与每种药物的作用和代谢有关。此外,在评价药物的抗肿瘤作用方面,自动模拟系统优于常规培养系统。同时也提示CA比TB更适合作为判断细胞生长抑制效果的方法。目前,我们正在利用自动模拟系统研究同时模拟ara-C和DNR条件下的细胞生长抑制。
英文摘要
It is very important to study the metabolism and action of antileukemic agents under the condition which precisely reflect the clinical pharmacokinetics. In this year, we studied cell growth inhibition of leukemic cell line (K562) by cytosine arabinoside (ara-C), using method of trypan blue dye exclusion assay (TB) and clonogenic assay (CA) under the drug concentration regulated by automatic simulation system which was established last year. Under the condition of clinically regular dose ara-C (100mg/m_2) and equal area under the curve (AUC) each other, the cell growth by 2,4,8,16 hour infusion was 73%, 53%, 39%, 45% using TB,and 76%, 72%, 34%, 15% using CA respectively, compared with control. More obvious time dependent inhibition by ara-C was observed using CA.We also compared the effect of daunorubicin (DNR) by simulation method with the data by conventional culture system. The cell growth was 82% of the control using CA under simulated condition with DNR 40mg/m_2 30min.infusion (Cmax ; 0.20 muM,t1/2beta ; 4.35 hr). On the other side, 0.022 muM was required to get the same growth inhibition effect by 24 hours incubation under condition of conventional culture system. About 9 times higher concentration was required in automatic simulation system compared with conventional culture system. This result was different from the the case with the ara-C in last year where the difference was about 80 times, suggesting the difference might depend on the action and metabolism of each drug. In addition, it was suggested that to estimate the anti-tumor effect of drug, automatic simulation system is superior than conventional culture system. And it was also suggested that CA was better method than TB to judge the cell growth inhibition effect. Now we are studying cell growth inhibition under condition to simulate ara-C and DNR simultaneously using automatic simulation system.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Tohyama, K.: "Altered responses of purified blast cells from the myelodysplastic syndromes to colony-stimulating factors in vitro : comparison with normal blast cells." Exp. Hematol.22. 539-545 (1994)
Tohyama, K.:“骨髓增生异常综合征纯化母细胞对体外集落刺激因子反应的改变:与正常母细胞的比较。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
上田孝典: "抗白血病薬-新薬と合理的投与法の試み-" 臨床血液. 37. 635-639 (1996)
Takanori Ueda:“抗白血病药物-新药试验和合理给药方法”《临床血液》37。635-639(1996)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fukushima,T.: "Superior cytotoxic potency of mitoxantrone in interaction with DNA : Comparison with that of daunorubicin" Oncol.Res.8・2. 95-100 (1996)
Fukushima, T.:“米托蒽醌与 DNA 相互作用的卓越细胞毒性效力:与柔红霉素的比较”Oncol.Res.8・2 (1996)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ueda,T.: "Recent developments with novel anthracyclines for the treatment of haematological malignancies" Exp.Opin.Invest.Drugs. 5. 1639-1646 (1996)
Ueda,T.:“新型蒽环类药物治疗血液恶性肿瘤的最新进展”Exp.Opin.Invest.Drugs。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kawasaki,N.: "Cardiac energy metabolism at several stages of adriamycin-induced heart failure in rats" Int.J.Cardiol.55. 217-225 (1996)
Kawasaki,N.:“阿霉素诱导的大鼠心力衰竭几个阶段的心脏能量代谢”Int.J.Cardiol.55。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 27 条
A comparative study on legalization of lifelong learning policy in China
-
批准号:26381121
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2014
-
负责人:UEDA Takanori
-
依托单位:
Eliminating CPU Bottleneck of File I/O on Ultra High Speed Storage Environments
-
批准号:23650053
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.58万
-
财政年份:2011
-
负责人:UEDA Takanori
-
依托单位:
A File Cache Mechanism Considering Access Cost and Being Suitable for Many-core CPU Environment
-
批准号:21800061
-
项目类别:Grant-in-Aid for Research Activity Start-up
-
资助金额:$1.7万
-
财政年份:2009
-
负责人:UEDA Takanori
-
依托单位:
Tailor-made therapy based on pharmacogenomic strategy for refractory leukemia due to multifactorial drug resistance
-
批准号:19591102
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:UEDA Takanori
-
依托单位:
Establishment of taylor-made therapy of acute leukemia by means of pharmacogenetics
-
批准号:15590999
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:UEDA Takanori
-
依托单位:
Prediction of anticancer effect of 1-p-D-arabinofuranosylcytostee by sensitive monitoring of its intracellular active metabolite in leukemic cells
-
批准号:10670938
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:1998
-
负责人:UEDA Takanori
-
依托单位:
海外基金